Recent developments have suggested that HIPK2 deregulation by hyperglycemia may play a role not only in the chemoresistance of various cancer cell types but also in the progression of some diabetes complications, likely involving the same HIPK2-triggered molecular pathways. The gene discussed is HIPK2; the disease is Hyperglycemia.